Company Filing History:
5 out of 25 
2 out of 27 
1 out of 19 Years Active: 2014-2019
Title: Exploring the Innovations of Inventor Yiping Li from Hvidovre, Denmark
Introduction: Yiping Li, a distinguished inventor based in Hvidovre, Denmark, has made significant contributions to the field of hepatitis C virus (HCV) research. With a remarkable portfolio of five patents, he is recognized for his innovative approaches that aid in fundamental research and the development of potential vaccines against HCV.
Latest Patents: Among his latest innovations, Yiping Li has patented two critical inventions:
1. **Optimized HCV Full-Length Infectious Cell Culture Systems and Applications Thereof:** This invention relates to nucleic acid sequences encoding hepatitis C viruses (HCV) that are instrumental in fundamental research and vaccine development. The disclosed sequences express the virus when transfected into cells and demonstrate infectivity in vivo.
2. **High-Titer HCV Full-Length Genotype 2B Infectious Cell Culture Systems and Applications Thereof:** Similar to his first patent, this invention focuses on genotype 2b HCV sequences, providing tools for research and vaccine exploration. The capability of these sequences to express the virus and induce infection in vivo is a significant step forward in HCV studies.
Career Highlights: Yiping Li has built an impressive career primarily at Hvidovre Hospital and Københavns Universitet (University of Copenhagen). His work at these institutions emphasizes the importance of his research in the medical and scientific communities.
Collaborations: Throughout his career, Yiping Li has collaborated with esteemed colleagues, including Jens Bukh and Santseharay Ramirez Almeida. These partnerships have likely contributed to the depth and impact of his research endeavors, fostering innovation in the study of hepatitis C.
Conclusion: Yiping Li stands out as an influential inventor whose work has progressive implications for hepatitis C research. With his patents, he not only advances scientific knowledge but also paves the way for potential breakthrough treatments and vaccines. His contributions solidify his place in the landscape of innovative medical research, furthering our understanding of viral pathogens.